End-of-day quote
Mauritius S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
11
MUR
|
-.--%
|
|
-.--%
|
+4.76%
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,510
|
1,619
|
2,474
|
11,228
|
9,803
|
5,699
|
Enterprise Value (EV)
1 |
1,823
|
1,947
|
3,516
|
12,241
|
10,641
|
6,944
|
P/E ratio
|
-77.2
x
|
14.1
x
|
58.6
x
|
40.6
x
|
25.5
x
|
17.7
x
|
Yield
|
-
|
-
|
4.61%
|
1.37%
|
2.33%
|
3.4%
|
Capitalization / Revenue
|
0.87
x
|
0.85
x
|
1.24
x
|
4.46
x
|
3.34
x
|
1.82
x
|
EV / Revenue
|
1.05
x
|
1.02
x
|
1.76
x
|
4.86
x
|
3.63
x
|
2.21
x
|
EV / EBITDA
|
15.1
x
|
10.1
x
|
14.5
x
|
29
x
|
16.9
x
|
12
x
|
EV / FCF
|
11
x
|
-65.9
x
|
48.6
x
|
40.5
x
|
40.7
x
|
-83.8
x
|
FCF Yield
|
9.1%
|
-1.52%
|
2.06%
|
2.47%
|
2.46%
|
-1.19%
|
Price to Book
|
2.3
x
|
1.99
x
|
3.08
x
|
13.6
x
|
9.23
x
|
4.73
x
|
Nbr of stocks (in thousands)
|
569,941
|
569,941
|
569,941
|
569,941
|
569,941
|
569,941
|
Reference price
2 |
2.650
|
2.840
|
4.340
|
19.70
|
17.20
|
10.00
|
Announcement Date
|
11/26/18
|
9/24/19
|
11/16/20
|
10/22/21
|
9/18/23
|
9/18/23
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,737
|
1,909
|
1,992
|
2,519
|
2,933
|
3,138
|
EBITDA
1 |
120.7
|
192.1
|
243.2
|
422.3
|
630.3
|
579.6
|
EBIT
1 |
6.938
|
80.91
|
156.1
|
332.9
|
517.4
|
439.6
|
Operating Margin
|
0.4%
|
4.24%
|
7.84%
|
13.22%
|
17.64%
|
14.01%
|
Earnings before Tax (EBT)
1 |
-15.79
|
65.48
|
42.1
|
277.4
|
463.9
|
384.6
|
Net income
1 |
-19.56
|
114.9
|
42.22
|
276.7
|
384.6
|
321.7
|
Net margin
|
-1.13%
|
6.02%
|
2.12%
|
10.98%
|
13.11%
|
10.25%
|
EPS
2 |
-0.0343
|
0.2015
|
0.0741
|
0.4855
|
0.6747
|
0.5644
|
Free Cash Flow
1 |
165.9
|
-29.55
|
72.39
|
302.3
|
261.5
|
-82.84
|
FCF margin
|
9.55%
|
-1.55%
|
3.63%
|
12%
|
8.92%
|
-2.64%
|
FCF Conversion (EBITDA)
|
137.41%
|
-
|
29.77%
|
71.6%
|
41.5%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
171.47%
|
109.27%
|
68.01%
|
-
|
Dividend per Share
|
-
|
-
|
0.2000
|
0.2700
|
0.4000
|
0.3400
|
Announcement Date
|
11/26/18
|
9/24/19
|
11/16/20
|
10/22/21
|
9/18/23
|
9/18/23
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
313
|
328
|
1,042
|
1,013
|
838
|
1,244
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.592
x
|
1.707
x
|
4.285
x
|
2.398
x
|
1.329
x
|
2.147
x
|
Free Cash Flow
1 |
166
|
-29.5
|
72.4
|
302
|
262
|
-82.8
|
ROE (net income / shareholders' equity)
|
-2.9%
|
15.8%
|
5.23%
|
34%
|
40.8%
|
28.4%
|
ROA (Net income/ Total Assets)
|
0.26%
|
2.88%
|
4.49%
|
7.76%
|
10.6%
|
7.71%
|
Assets
1 |
-7,563
|
3,982
|
940.9
|
3,564
|
3,637
|
4,173
|
Book Value Per Share
2 |
1.150
|
1.420
|
1.410
|
1.450
|
1.860
|
2.120
|
Cash Flow per Share
2 |
0.2700
|
0.2200
|
0.2800
|
0.4200
|
0.7000
|
0.4200
|
Capex
1 |
69.5
|
93.8
|
85.8
|
181
|
366
|
455
|
Capex / Sales
|
4%
|
4.91%
|
4.31%
|
7.19%
|
12.48%
|
14.5%
|
Announcement Date
|
11/26/18
|
9/24/19
|
11/16/20
|
10/22/21
|
9/18/23
|
9/18/23
|
|
1st Jan change
|
Capi.
|
---|
| +4.76% | 135M | | +13.94% | 81.84B | | -30.88% | 70.69B | | +9.37% | 29.03B | | -12.24% | 16.97B | | -0.36% | 16.83B | | -1.50% | 15.28B | | +5.90% | 12.41B | | +35.98% | 12.26B | | -4.20% | 11.86B |
Other Healthcare Facilities & Services
|